P21

Buy P21 Online

P21, also referred to as P021, is an experimental neurotrophic peptide mimetic derived from a region of ciliary neurotrophic factor (CNTF). It has attracted research interest primarily for its potential effects on neurogenesis, synaptic plasticity, memory, and neurodegenerative disease pathways.

Product Information

P021 is a small peptidergic compound designed from a biologically active region of CNTF. Structural modification was used to improve its stability and blood-brain barrier permeability, allowing the compound to be investigated through oral administration in animal models.

Research has reported effects on BDNF expression, neurogenesis, tau pathology, and cognitive performance in several preclinical models. Importantly, these findings remain predominantly preclinical and should not be interpreted as evidence of established human efficacy.

How It Works

P021 appears to promote neurotrophic signaling partly by inhibiting leukemia inhibitory factor (LIF) signaling and increasing transcription and expression of brain-derived neurotrophic factor (BDNF). Increased BDNF activity may support neurogenesis and synaptic plasticity, while downstream effects on GSK-3β have been investigated in relation to tau phosphorylation.

POTENTIAL BENEFITS

1. Cognitive Research

P021 has demonstrated promising cognitive effects in aging and Alzheimer's-disease animal models. Chronic oral administration has been associated with improved learning and memory performance, making it an interesting candidate for research into age-related cognitive decline.

2. Neurogenesis Research

Research has found that P021 can increase neurogenesis and influence the development of new neurons. This makes the compound particularly relevant to studies examining how neurotrophic signaling may support brain plasticity during aging or neurological disease.

3. BDNF-Related Research

P021 has been shown in preclinical research to increase BDNF expression. Because BDNF plays an important role in neuronal survival, synaptic plasticity, and learning, this mechanism is a major reason for the compound's continued research interest.

4. Tau and Alzheimer's Research

Animal studies have reported reductions in abnormal tau phosphorylation following P021 treatment. Research has linked these effects to changes in BDNF and GSK-3β signaling, making P021 particularly interesting for Alzheimer's disease research.

5. Brain Plasticity Research

By combining neurogenic and neurotrophic activity, P021 provides researchers with a model for investigating how neurotrophic compounds can influence neuronal development and synaptic function. Preclinical work has reported effects on synaptic markers and cognitive behavior.

Dosage

No established human dosage exists for P21/P021.

Published research has used experimental doses in animal models, including chronic oral administration, but these animal doses cannot be directly translated into a human supplementation protocol. Commercially marketed products sold as “P21” or “P21-adamantane” may also differ chemically from the P021 compound described in peer-reviewed research.

Side Effects

Human safety data are insufficient to establish a complete side-effect profile. Potential concerns include:

• Unknown long-term safety
• Individual sensitivity
• Unknown interactions with neurological medications
• Lack of established human pharmacokinetic data

References

1. Tran T, et al. Rescue of cognitive aging by administration of a neurogenic and/or neurotrophic compound. PMID: 24702821. PubMed
2. Neurotrophic factor small-molecule mimetics mediated neuroregeneration and synaptic repair. PMID: 27400746. PubMed
3. Falangola MF, et al. Diffusion MRI measures detect brain microstructure changes due to early treatment with neurotrophic peptide mimetic P021 in the 3xTg-AD mouse model of Alzheimer's disease. PMID: 41740658. PubMed

Note: BehemothLabz does not sell this product. Purchase links on this page may direct you to third-party suppliers through affiliate links.

Please click here to see how purchases actually work on this site.